We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+7.29%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$22.1B
AUM Growth
+$302M
Cap. Flow
-$1.3B
Cap. Flow %
-5.9%
Top 10 Hldgs %
11.41%
Holding
3,562
New
1,146
Increased
641
Reduced
606
Closed
971

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$148M
2
NFLX icon
Netflix
NFLX
+$119M
3
ABNB icon
Airbnb
ABNB
+$111M
4
XYZ
Block Inc
XYZ
+$89.5M
5
DHR icon
Danaher
DHR
+$88.6M

Top Sells

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$212M
2
BABA icon
Alibaba
BABA
+$172M
3
ZTS icon
Zoetis
ZTS
+$133M
4
TRU icon
TransUnion
TRU
+$124M
5
BIDU icon
Baidu
BIDU
+$111M

Sector Composition

Rank Sector Weight
1 Healthcare 20.88%
2 Financials 13.4%
3 Consumer Discretionary 12.06%
4 Technology 11.2%
5 Communication Services 8.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FACT.U
3251
DELISTED
Freedom Acquisition I Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
FACT.U
-1,189,751
Closed -$11.9M
FMIVU
3252
DELISTED
Forum Merger IV Corporation Unit
FMIVU
-900,000
Closed -$8.91M
USX
3253
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
-11,393
Closed -$134K
HEXO
3254
DELISTED
HEXO Corp. Common Shares
HEXO
-2,729
Closed -$247K
ONCR
3255
DELISTED
Oncorus, Inc.
ONCR
-53,953
Closed -$751K
DCP
3256
DELISTED
DCP Midstream, LP
DCP
-45,686
Closed -$990K
RUTH
3257
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
-62,445
Closed -$1.55M
APTO
3258
DELISTED
Aptose Biosciences, Inc.
APTO
-1,477
Closed -$3.97M
TCRR
3259
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
-22,211
Closed -$491K
SUMO
3260
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
-13,059
Closed -$246K
BBBY
3261
DELISTED
Bed Bath & Beyond Inc
BBBY
-266,133
Closed -$7.76M
FRC
3262
DELISTED
First Republic Bank
FRC
-18,845
Closed -$3.14M
PRVB
3263
DELISTED
Provention Bio, Inc. Common Stock
PRVB
-24,416
Closed -$256K
IPVIU
3264
DELISTED
InterPrivate IV InfraTech Partners Inc. Units
IPVIU
-800,902
Closed -$7.92M
TWNI.U
3265
DELISTED
Tailwind International Acquisition Corp. Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
TWNI.U
-489,678
Closed -$4.84M
DHHCU
3266
DELISTED
DiamondHead Holdings Corp. Unit
DHHCU
-290,070
Closed -$2.88M
MSDAU
3267
DELISTED
MSD Acquisition Corp. Unit
MSDAU
-1,000,000
Closed -$10.2M
TETCU
3268
DELISTED
Tech and Energy Transition Corporation Unit
TETCU
-1,351,507
Closed -$13.5M
CRZNU
3269
DELISTED
Corazon Capital V838 Monoceros Corp Unit
CRZNU
-750,000
Closed -$7.46M
STRE.U
3270
DELISTED
Supernova Partners Acquisition Company III, Ltd. Units, each consisting of one Class A ordinary share and one-fifth of one redeemable warrant
STRE.U
-750,000
Closed -$7.5M
LVRAU
3271
DELISTED
Levere Holdings Corp. Unit
LVRAU
-1,000,000
Closed -$9.96M
VPCBU
3272
DELISTED
VPC Impact Acquisition Holdings II Unit
VPCBU
-750,000
Closed -$7.39M
GXIIU
3273
DELISTED
GX Acquisition Corp. II Unit
GXIIU
-1,499,900
Closed -$14.9M
BGSX.U
3274
DELISTED
Build Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant
BGSX.U
-600,000
Closed -$5.92M
FRONU
3275
DELISTED
Frontier Acquisition Corp. Units
FRONU
-510,603
Closed -$5.07M

Similar funds

Marshall Wace's Q2 2021 Portfolio in Review

As of Q2 2021, Marshall Wace held 3,562 positions worth $22.1B, up 1.4% from $21.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Marshall Wace withdrew a net $1.3B in Q2 2021, closing 971 positions and reducing 606 holdings. Its most notable exit was Pinterest, an estimated $88.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Marshall Wace opened a new position in West Pharmaceutical worth $55.8M.

  • Marshall Wace's largest Q2 2021 buy was West Pharmaceutical: 155,316 shares worth $55.8M.
  • Marshall Wace added most to Biogen in Q2 2021, an estimated $148M increase.
  • Marshall Wace's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $212M.
  • Marshall Wace fully exited Pinterest in Q2 2021, selling an estimated $88.8M.
  • Marshall Wace's ten largest holdings make up 11% of its $22.1B portfolio in Q2 2021.
  • Marshall Wace opened 1,146 new positions and closed 971 in Q2 2021.
  • Marshall Wace's portfolio value rose 1.4% quarter-over-quarter to $22.1B.

Based on Marshall Wace's 13F filing for Q2 2021, filed 13 Aug 2021.